Byhealth Co., Ltd

300146

CNE100000Y84

Food Processing

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
15.65 ^CNY	+1.56%		-4.46%	-8.10%

Apr. 25	Byhealth Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 12	Byhealth Co., Ltd Approves Cash Dividend for the Year 2023	CI

Tranche Update on Byhealth Co., Ltd's Equity Buyback Plan announced on November 1, 2023.

January 04, 2024 at 06:20 am EST

From October 30, 2023 to December 31, 2023, the company has repurchased 1,000,000 shares, representing 0.06% for CNY 17.99 million. With this, the company has completed the repurchase of 1,000,000 shares, representing 0.06% for CNY 17.99 million under the buyback announced on November 1, 2023.

Latest news about Byhealth Co., Ltd

Byhealth Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Byhealth Co., Ltd Approves Cash Dividend for the Year 2023	Apr. 12	CI
Tranche Update on Byhealth Co., Ltd's Equity Buyback Plan announced on November 1, 2023.	Apr. 01	CI
Byhealth Co., Ltd Announces Profit Distribution Proposal for 2023	Mar. 19	CI
BY-Health's 2023 Profit Rises 26% as Revenue Jumps 20%	Mar. 19	MT
Byhealth Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 20	CI
Tranche Update on Byhealth Co., Ltd's Equity Buyback Plan announced on November 1, 2023.	Jan. 04	CI
Byhealth Co., Ltd announces an Equity Buyback for CNY 300 million worth of its shares.	Nov. 01	CI
Byhealth Co., Ltd authorizes a Buyback Plan.	23-10-29	CI
Byhealth Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-24	CI
Provexis notes regulatory filing for Fruitflow in China	23-08-30	AN
Provexis' Local Partner Files for New Health Function Claim for Foods in China; Rises 12%	23-08-30	MT
Provexis plc Announces Byhealth Co., Ltd Regulatory Filing with Chinese SAMR	23-08-30	CI
Byhealth Co. Ltd. Approves Executive Appointments	23-08-25	CI
Byhealth Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-04	CI
Byhealth Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Byhealth Co.,Ltd Announces Final Dividend Share A for 2022, Payable on April 21, 2023	23-04-17	CI
Byhealth Co.,Ltd Approves Dividend for the Year 2022	23-04-11	CI
Byhealth Co.,Ltd Proposes Final Cash Dividend for 2022	23-03-20	CI
BY-Health Sees Up to 30% Profit Slump in 2022	23-01-03	MT
By-health Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25	CI
By-health Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-05	CI
By-health Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
By-Health Co., Ltd. Implements Cash Dividend for 2021, Payable on 13 April 2022	22-04-06	CI
By-Health Co., Ltd. Approves Cash Dividend for 2021	22-03-28	CI

Chart Byhealth Co., Ltd

Duration

Period

More charts

Company Profile

By-health Co Ltd is a China-based company principally engaged in the research, development, production, and distribution of nutrition supplements. The Company's main products include protein powders, collagen protein, vitamin C tablets, vitamin B tablets, natural vitamin E capsules, vitamin A and D soft capsules, calcium and vitamin D soft capsules, bovine colostrum calcium tablets, bone collagen calcium tablets, spirulina tablets, grape seed tablets, wheat germ oil soft capsules, deep-sea fish oil soft capsules, tuna oil soft capsules, propolis soft capsules, soybean phospholipids soft capsules and squalene soft capsules, among others. The Company distributes products both in the domestic market and to overseas markets.

Sector

Food Processing

Calendar

2024-08-04 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Byhealth Co., Ltd

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

15.65 CNY

Average target price

22.99 CNY

Spread / Average Target

+46.91%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
BYHEALTH CO., LTD	-8.10%	3.67B
ZHEJIANG NHU COMPANY LTD.	+8.20%	7.78B
BELLRING BRANDS, INC.	+0.34%	7.38B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+10.20%	6.52B
THE SIMPLY GOOD FOODS COMPANY	-13.13%	3.44B
XIAMEN KINGDOMWAY GROUP COMPANY	-14.57%	1.17B
SIRIO PHARMA CO., LTD.	+8.34%	934M
HERBALIFE LTD.	-42.27%	879M
USANA HEALTH SCIENCES, INC.	-18.90%	836M
GRAPE KING BIO LTD	+0.32%	711M

Special Foods & Wellbeing Products

Byhealth Co., Ltd

Equities

300146

CNE100000Y84

Food Processing

Tranche Update on Byhealth Co., Ltd's Equity Buyback Plan announced on November 1, 2023.

Latest news about Byhealth Co., Ltd

Chart Byhealth Co., Ltd

Company Profile

Income Statement Evolution

Ratings for Byhealth Co., Ltd

Analysts' Consensus

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Special Foods & Wellbeing Products